Practice Areas - Corporate and M&A Law Firms and Lawyers
Deal Date: | 08-04-2016 | Practice Area: | Corporate and M&A |
Deal Title: | Formation of the Gyros Protein Technologies Group | Industry: | Pharmaceuticals & Biotechnology |
Description: |
Vinge advised Ampersand Capital Partners, a Boston based private equity firm, in connection with the formation of the Gyros Protein Technologies group. The new group consisted of Ampersand's portfolio company Protein Technologies, Inc., a US based provider of peptide synthesis instrumentation and reagents, and the Swedish Gyros group operating within automated nanoliter-scale immunoassays, who's majority owner was the Swedish Sixth National Pension Fund.
|
||
Financial Center: | Stockholm | Value: | 0.00-0.00 |
Advised Party: | Joint Venture Party | Law Firm | Vinge |
JV Party Jurisdiction | Sweden | JV Party Jurisdiction | United States |
Classification: |
Joint Ventures Continuing Business Partnership |
Lawyer | Christina Kokko |